PPIB and Other metabolic disease: As demonstrated in our study, the expression level of CypB was only enhanced in the liver, VAT, and SAT, rather than in the lung, kidney, and heart in murine models of obesity, suggesting that CypB may contribute to the effect of these organs and tissue, leading to metabolic disorder.